Dysregulation of GRK2 expression or activity has been found to be involved in several pathological conditions, including cardiovascular disease, obesity, insulin resistance, and cancer where, GRK2 upregulation can affect β-adrenergic receptor function and exacerbate disease progression [17]. Here, GRK2 is linked to obesity due to melanocortin 4 receptor deficiency.